Total Payments
$20,400
2024 Payments
$6,252
Companies
28
Transactions
1,014
Medicare Patients
2,672
Medicare Billing
$161,586
Payment Breakdown by Category
Food & Beverage$19,711 (96.6%)
Education$688.50 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,711 | 1,005 | 96.6% |
| Education | $688.50 | 9 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,499 | 162 | $0 (2024) |
| Janssen Biotech, Inc. | $2,620 | 118 | $0 (2024) |
| Lilly USA, LLC | $2,086 | 85 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,723 | 104 | $0 (2024) |
| UCB, Inc. | $1,352 | 77 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,029 | 42 | $0 (2024) |
| Amgen Inc. | $949.17 | 51 | $0 (2023) |
| Incyte Corporation | $871.80 | 41 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $862.34 | 41 | $0 (2024) |
| Dermavant Sciences, Inc. | $824.68 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,252 | 275 | Janssen Biotech, Inc. ($894.63) |
| 2023 | $5,926 | 279 | ABBVIE INC. ($989.53) |
| 2022 | $4,465 | 238 | ABBVIE INC. ($908.04) |
| 2021 | $3,757 | 222 | AbbVie Inc. ($801.17) |
All Payment Transactions
1,014 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: Immunology | ||||||
| 12/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.53 | General |
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $33.21 | General |
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Immunology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Immunology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Immunology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 740 | 1,411 | $179,040 | $45,015 |
| 2022 | 10 | 1,031 | 1,916 | $250,765 | $62,318 |
| 2021 | 10 | 866 | 1,474 | $201,530 | $53,029 |
| 2020 | 2 | 35 | 36 | $5,750 | $1,224 |
Total Patients
2,672
Total Services
4,837
Medicare Billing
$161,586
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 218 | 259 | $45,325 | $14,673 | 32.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 103 | 105 | $31,500 | $7,118 | 22.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 120 | 144 | $28,800 | $6,137 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 96 | 96 | $21,600 | $6,109 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 58 | 64 | $17,600 | $4,599 | 26.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 104 | 698 | $20,940 | $3,256 | 15.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $8,075 | $2,100 | 26.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 23 | 26 | $5,200 | $1,023 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 243 | $42,525 | $12,948 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 171 | 179 | $53,700 | $12,520 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 171 | 171 | $38,475 | $11,342 | 29.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 160 | 182 | $36,400 | $8,300 | 22.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 82 | 89 | $24,475 | $6,615 | 27.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 139 | 943 | $28,290 | $4,549 | 16.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 51 | 59 | $11,800 | $2,323 | 19.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 19 | 20 | $8,500 | $2,303 | 27.1% |
| 69100 | Biopsy of ear | Office | 2022 | 15 | 16 | $5,200 | $959.15 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,400 | $458.25 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 236 | 272 | $47,600 | $15,522 | 32.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 151 | 155 | $46,500 | $11,216 | 24.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 117 | 117 | $26,325 | $8,386 | 31.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 128 | 148 | $29,600 | $6,484 | 21.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 55 | 61 | $16,775 | $4,735 | 28.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 100 | 636 | $19,080 | $2,863 | 15.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 42 | 46 | $9,200 | $1,848 | 20.1% |
About Yelena Kisel, NP
Yelena Kisel, NP is a Family healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1619201654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yelena Kisel, NP has received a total of $20,400 in payments from pharmaceutical and medical device companies, with $6,252 received in 2024. These payments were reported across 1,014 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($19,711).
As a Medicare-enrolled provider, Kisel has provided services to 2,672 Medicare beneficiaries, totaling 4,837 services with total Medicare billing of $161,586. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Worcester, MA
- Active Since 09/23/2009
- Last Updated 09/23/2009
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619201654
Products in Payments
- TREMFYA (Drug) $2,277
- DUPIXENT (Biological) $1,902
- TALTZ (Drug) $1,745
- SKYRIZI (Biological) $1,660
- RINVOQ (Biological) $1,269
- OPZELURA (Drug) $871.80
- COSENTYX (Biological) $840.94
- VTAMA (Drug) $824.68
- Otezla (Drug) $815.51
- Sotyktu (Drug) $746.14
- Bimzelx (Biological) $716.73
- EUCRISA (Drug) $707.12
- Cimzia (Drug) $635.28
- HUMIRA (Biological) $467.90
- COSENTYX (Drug) $462.02
- REMICADE (Biological) $456.75
- Winlevi (Drug) $400.16
- ENSTILAR (Drug) $317.15
- AKLIEF (Drug) $264.98
- ILUMYA (Biological) $231.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Worcester
Raichel Topale, Np, NP
Family — Payments: $13,013
Family $13,013
Phoebe Amoako
Family — Payments: $3,901
Family $3,901
Zachary Henderson, Fnp, FNP
Family — Payments: $2,393
Family $2,393
Brianna Vega, Fnp, FNP
Family — Payments: $1,655
Family $1,655
Viana Bernard, Fnp, FNP
Family — Payments: $1,266
Family $1,266
Mrs. Kathleen Spadoni, Fnp-Bc, FNP-BC
Family — Payments: $1,162
Family $1,162